Tobias John
Research Subjects
Tobias John has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Schofield
Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK
7 shared publications - C. David Owen
Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot, UK, OX11 0FA
3 shared publications - Claire Strain-Damerell
Diamond Light Source Ltd., Harwell Science and Innovation Campus
3 shared publications - Fernanda Duarte
University of Oxford
3 shared publications - Ho Ting Henry Chan
Department of Chemistry, Hong Kong Baptist University, Hong Kong SAR, China, hkbu.edu.hk
3 shared publications - Martin Austin Walsh
Diamond Light Source Ltd., Harwell Science and Innovation Campus, Didcot, UK
3 shared publications
Latest Publications
- 25 November 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 286-287
New technologies for production of recombinant spider silk
- 25 November 2025
- Published by Elsevier in Trends in Biotechnology
- Vol. 44 (1) , 286-287
New technologies for production of recombinant spider silk
- Open Access
- 15 January 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (7) , 2509-2517
Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism
Asparagine levels are reduced in patients with diabetes and alcoholism. A plausible mechanism is that aldehydes elevated in these diseases react with the N-terminal cysteine of asparagine synthetase B, so inhibiting asparagine production.
- 15 January 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (7) , 2509-2517
Open AccessAldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism
Asparagine levels are reduced in patients with diabetes and alcoholism. A plausible mechanism is that aldehydes elevated in these diseases react with the N-terminal cysteine of asparagine synthetase B, so inhibiting asparagine production.
- Open Access
- 1 November 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-16
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
Cancer linked isocitrate dehydrogenase (IDH) 1 variants, notably R132H IDH1, manifest a ‘gain-of-function’ to reduce 2-oxoglutarate to 2-hydroxyglutarate. High-throughput screens have enabled clinically useful R132H IDH1 inhibitors, mostly allosteric binders at the dimer interface. We report investigations on roles of divalent metal ions in IDH substrate and inhibitor binding that rationalise this observation. Mg2+/Mn2+ ions enhance substrate binding to wt IDH1 and R132H IDH1, but with the former manifesting lower Mg2+/Mn2+KMs. The isocitrate-Mg2+ complex is the preferred wt IDH1 substrate; with R132H IDH1, separate and weaker binding of 2-oxoglutarate and Mg2+ is preferred. Binding of R132H IDH1 inhibitors at the dimer interface weakens binding of active site Mg2+ complexes; their potency is affected by the Mg2+ concentration. Inhibitor selectivity for R132H IDH1 over wt IDH1 substantially arises from different stabilities of wt and R132H IDH1 substrate-Mg2+ complexes. The results reveal the importance of substrate-metal ion complexes in wt and R132H IDH1 catalysis and the basis for selective R132H IDH1 inhibition. Further studies on roles of metal ion complexes in TCA cycle and related metabolism, including from an evolutionary perspective, are of interest.
- 1 November 2021
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-16
Open AccessRoles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
Cancer linked isocitrate dehydrogenase (IDH) 1 variants, notably R132H IDH1, manifest a ‘gain-of-function’ to reduce 2-oxoglutarate to 2-hydroxyglutarate. High-throughput screens have enabled clinically useful R132H IDH1 inhibitors, mostly allosteric binders at the dimer interface. We report investigations on roles of divalent metal ions in IDH substrate and inhibitor binding that rationalise this observation. Mg2+/Mn2+ ions enhance substrate binding to wt IDH1 and R132H IDH1, but with the former manifesting lower Mg2+/Mn2+KMs. The isocitrate-Mg2+ complex is the preferred wt IDH1 substrate; with R132H IDH1, separate and weaker binding of 2-oxoglutarate and Mg2+ is preferred. Binding of R132H IDH1 inhibitors at the dimer interface weakens binding of active site Mg2+ complexes; their potency is affected by the Mg2+ concentration. Inhibitor selectivity for R132H IDH1 over wt IDH1 substantially arises from different stabilities of wt and R132H IDH1 substrate-Mg2+ complexes. The results reveal the importance of substrate-metal ion complexes in wt and R132H IDH1 catalysis and the basis for selective R132H IDH1 inhibition. Further studies on roles of metal ion complexes in TCA cycle and related metabolism, including from an evolutionary perspective, are of interest.
- Open Access
- 6 September 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (41) , 13686-13703
Discovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding
The main protease (Mpro) of SARS-CoV-2 is central to viral maturation and is a promising drug target. In silico methods reveal structural aspects of how it binds to its 11 natural cleavage sites, the design of novel peptide inhibitors, and insights into drug design.
- 6 September 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 12 (41) , 13686-13703
Open AccessDiscovery of SARS-CoV-2 Mpro peptide inhibitors from modelling substrate and ligand binding
The main protease (Mpro) of SARS-CoV-2 is central to viral maturation and is a promising drug target. In silico methods reveal structural aspects of how it binds to its 11 natural cleavage sites, the design of novel peptide inhibitors, and insights into drug design.
- Open Access
Discovery of SARS-CoV-2 M pro Peptide Inhibitors from Modelling Substrate and Ligand Binding
The main protease (M pro ) of SARS-CoV-2 is central to its viral lifecycle and is a promising drug target, but little is known concerning structural aspects of how it binds to its 11 natural cleavage sites. We used biophysical and crystallographic data and an array of classical molecular mechanics and quantum mechanical techniques, including automated docking, molecular dynamics (MD) simulations, linear-scaling DFT, QM/MM, and interactive MD in virtual reality, to investigate the molecular features underlying recognition of the natural M pro substrates. Analyses of the subsite interactions of modelled 11-residue cleavage site peptides, ligands from high-throughput crystallography, and designed covalently binding inhibitors were performed. Modelling studies reveal remarkable conservation of hydrogen bonding patterns of the natural M pro substrates, particularly on the N-terminal side of the scissile bond. They highlight the critical role of interactions beyond the immediate active site in recognition and catalysis, in particular at the P2/S2 sites. The binding modes of the natural substrates, together with extensive interaction analyses of inhibitor and fragment binding to M pro , reveal new opportunities for inhibition. Building on our initial M pro -substrate models, computational mutagenesis scanning was employed to design peptides with improved affinity and which inhibit M pro competitively. The combined results provide new insight useful for the development of M pro inhibitors.
Open AccessDiscovery of SARS-CoV-2 M pro Peptide Inhibitors from Modelling Substrate and Ligand Binding
The main protease (M pro ) of SARS-CoV-2 is central to its viral lifecycle and is a promising drug target, but little is known concerning structural aspects of how it binds to its 11 natural cleavage sites. We used biophysical and crystallographic data and an array of classical molecular mechanics and quantum mechanical techniques, including automated docking, molecular dynamics (MD) simulations, linear-scaling DFT, QM/MM, and interactive MD in virtual reality, to investigate the molecular features underlying recognition of the natural M pro substrates. Analyses of the subsite interactions of modelled 11-residue cleavage site peptides, ligands from high-throughput crystallography, and designed covalently binding inhibitors were performed. Modelling studies reveal remarkable conservation of hydrogen bonding patterns of the natural M pro substrates, particularly on the N-terminal side of the scissile bond. They highlight the critical role of interactions beyond the immediate active site in recognition and catalysis, in particular at the P2/S2 sites. The binding modes of the natural substrates, together with extensive interaction analyses of inhibitor and fragment binding to M pro , reveal new opportunities for inhibition. Building on our initial M pro -substrate models, computational mutagenesis scanning was employed to design peptides with improved affinity and which inhibit M pro competitively. The combined results provide new insight useful for the development of M pro inhibitors.
- Open Access
- 19 January 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (12) , 1430-1433
Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M pro inhibitors
A high-throughput mass spectrometry based M pro assay identifies penicillin esters as new SARS-CoV-2 M pro inhibitors.
- 19 January 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (12) , 1430-1433
Open AccessMass spectrometry reveals potential of β-lactams as SARS-CoV-2 M pro inhibitors
A high-throughput mass spectrometry based M pro assay identifies penicillin esters as new SARS-CoV-2 M pro inhibitors.
- Open Access
- 21 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-5
Metampicillin is a cyclic aminal produced by reaction of ampicillin with formaldehyde
Metampicillin is a β-lactam antibiotic that is prepared by the reaction of ampicillin with formaldehyde. Although metampicillin has been studied for treatment of infections in animals and humans, its structure has been unclear. We report NMR studies revealing that metampicillin contains a formaldehyde-derived cyclic aminal. NMR time-course experiments with excess formaldehyde in solution show formation of another product with an additional exocyclic hemiaminal group formed by reaction with the cyclic aminal nitrogen. The exocyclic hemiaminal group is readily removed by reaction with the formaldehyde scavenger 1,3-cyclohexanedione, whereas the cyclic aminal methylene exhibits greater stability. The overall results assign the structure of metampicillin as containing a cyclic aminal and further reveal the potential for complexity in the reaction of formaldehyde with biomedicinally relevant molecules.
- 21 October 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-5
Open AccessMetampicillin is a cyclic aminal produced by reaction of ampicillin with formaldehyde
Metampicillin is a β-lactam antibiotic that is prepared by the reaction of ampicillin with formaldehyde. Although metampicillin has been studied for treatment of infections in animals and humans, its structure has been unclear. We report NMR studies revealing that metampicillin contains a formaldehyde-derived cyclic aminal. NMR time-course experiments with excess formaldehyde in solution show formation of another product with an additional exocyclic hemiaminal group formed by reaction with the cyclic aminal nitrogen. The exocyclic hemiaminal group is readily removed by reaction with the formaldehyde scavenger 1,3-cyclohexanedione, whereas the cyclic aminal methylene exhibits greater stability. The overall results assign the structure of metampicillin as containing a cyclic aminal and further reveal the potential for complexity in the reaction of formaldehyde with biomedicinally relevant molecules.
- Open Access
- 25 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (52) , 23544-23548
Allosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays**
The SARS‐CoV‐2 main protease (Mpro) cleaves along the two viral polypeptides to release non‐structural proteins required for viral replication. MPro is an attractive target for antiviral therapies to combat the coronavirus‐2019 disease. Here, we used native mass spectrometry to characterize the functional unit of Mpro. Analysis of the monomer/dimer equilibria reveals a dissociation constant of Kd=0.14±0.03 μM, indicating MPro has a strong preference to dimerize in solution. We characterized substrate turnover rates by following temporal changes in the enzyme‐substrate complexes, and screened small molecules, that bind distant from the active site, for their ability to modulate activity. These compounds, including one proposed to disrupt the dimer, slow the rate of substrate processing by ≈35 %. This information, together with analysis of the x‐ray crystal structures, provides a starting point for the development of more potent molecules that allosterically regulate MPro activity.
- 25 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (52) , 23544-23548
Open AccessAllosteric Inhibition of the SARS‐CoV‐2 Main Protease: Insights from Mass Spectrometry Based Assays**
The SARS‐CoV‐2 main protease (Mpro) cleaves along the two viral polypeptides to release non‐structural proteins required for viral replication. MPro is an attractive target for antiviral therapies to combat the coronavirus‐2019 disease. Here, we used native mass spectrometry to characterize the functional unit of Mpro. Analysis of the monomer/dimer equilibria reveals a dissociation constant of Kd=0.14±0.03 μM, indicating MPro has a strong preference to dimerize in solution. We characterized substrate turnover rates by following temporal changes in the enzyme‐substrate complexes, and screened small molecules, that bind distant from the active site, for their ability to modulate activity. These compounds, including one proposed to disrupt the dimer, slow the rate of substrate processing by ≈35 %. This information, together with analysis of the x‐ray crystal structures, provides a starting point for the development of more potent molecules that allosterically regulate MPro activity.
- Open Access
- 4 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-7
Formaldehyde quantification using ampicillin is not selective
Formaldehyde (HCHO) is a simple and highly reactive human metabolite but its biochemistry is poorly defined. A limiting factor in HCHO research is lack of validated quantification methods for HCHO relevant to biological samples. We describe spectroscopic studies on a reported fluorescence-based HCHO detection method involving its reaction with ampicillin. The results validate the structure and fluorescence properties of the HCHO-ampicillin reaction product. However, the same adduct is observed after reaction of ampicillin with glyoxylate. Related fluorophores were formed with other biologically relevant carbonyl compounds. Overall, our studies suggest the ampicillin method is not reliable for selective detection and quantification of HCHO in biological samples.
- 4 December 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-7
Open AccessFormaldehyde quantification using ampicillin is not selective
Formaldehyde (HCHO) is a simple and highly reactive human metabolite but its biochemistry is poorly defined. A limiting factor in HCHO research is lack of validated quantification methods for HCHO relevant to biological samples. We describe spectroscopic studies on a reported fluorescence-based HCHO detection method involving its reaction with ampicillin. The results validate the structure and fluorescence properties of the HCHO-ampicillin reaction product. However, the same adduct is observed after reaction of ampicillin with glyoxylate. Related fluorophores were formed with other biologically relevant carbonyl compounds. Overall, our studies suggest the ampicillin method is not reliable for selective detection and quantification of HCHO in biological samples.